Surowce roślinne stosowane w chorobach układu krążenia i serca

• Autorzy: Nowak G.

Warianty tytułu

EN

Herbal medicinals applied in cardiovascular and heart diseases

• Języki publikacji: PL

Abstrakty

PL

Zioła mogą być pomocne w leczeniu niewydolności krążenia, stabilnej postaci choroby wieńcowej. Surowce głogu mają istotne znaczenie w leczeniu niektórych stanów związanych z układem krążenia. W przeciwieństwie do kardenolidów zawartych w zielu miłka wiosennego i zielu konwalii majowej powodują one efekt chronotropowo i dronotropowo pozytywny. Fitoterapia odgrywa ważną rolę w terapii przewlekłej niewydolności żylnej i w leczeniu hemoroidów.

EN

Herbs may be helpful in the treatment of coronary disease in its stable form. The raw material of hawthorn play a big role in the treatment of several circulatory disorders. In contrast to cardenolides, contained in the herb of spring adonis and the herb of lily of the valley, they induce positive chronotropic and dronotropic effects. Phytotherapy plays an important role in venous insufficiency and haemorrhoids treatment.

Słowa kluczowe

PL

zielarstwo; ziololecznictwo; ziola; aminek egipski; Ammi visnaga; borowka czarna; Vaccinium myrtillus; czosnek pospolity; Allium sativum; dab bezszypulkowy; Quercus petraea; dab szypulkowy; Quercus robur; glog jednoszyjkowy; Crataegus monogyna; glog dwuszyjkowy; Crataegus laevigata; jemiola pospolita; Viscum album; kasztanowiec zwyczajny; Aesculus hippocastanum; konwalia majowa; Convallaria majalis; krwawnik pospolity; Achillea millefolium; lipa drobnolistna; Tilia cordata; lipa szerokolistna; Tilia platyphyllos; milek wiosenny; Adonis vernalis; milorzab dwuklapowy; Ginkgo biloba; nostrzyk zolty; Melilotus officinalis; oczar wirginijski; Hamamelis virginiana; rozmaryn lekarski; Rosmarinus officinalis; rumianek pospolity; Matricaria chamomilla; ruszczyk kolczasty; Ruscus aculeatus; serdecznik pospolity; Leonurus cardiaca; topola balsamiczna; Populus balsamifera; topola kanadyjska; Populus x canadensis; topola osika; Populus tremula; topola czarna; Populus nigra; surowce roslinne; surowce zielarskie; liscie; kwiaty; owoce; nasiona; fitoterapia; antocyjany; choroby ukladu krazenia; choroby serca; choroba wiencowa; nadcisnienie tetnicze; zylaki odbytu; leczenie; leki roslinne; leki hipotensyjne; dzialanie hipotensyjne

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2009
• Tom: 55
• Numer: 2
• Opis fizyczny: s.100-120,rys.,bibliogr.

Twórcy

autor

Nowak G.

• Katedra i Zakład Naturalnych Surowców Leczniczych i Kosmetycznych, Uniwersytet Medyczny im. Karola Marcinowskiego w Poznaniu, ul.Mazowiecka 33, 60-623 Poznań

Bibliografia

• 1. Chatterjee SS, Koch E, Jaggy H, Krzeminski T. In-vitro- und In-vivo-Untersuchungen zur kardioprotektiven Wirkung von oligomeren Procyanidinen in einem Crataegus-Extrakt aus Blättern mit Blüten. Arzneim Forsch/Drug Res. 1997; 47:821-5.
• 2. Zapfe G. jun. Clinical efficacy of Crataegus extract WS 1422 in congestive heart failure NYHA class II. Phytomedicine 2001; 8:262-6.
• 3. O rth-Wagner S, Scheurich E. Moderne Phytotherapie. Teil IV: Weissdorn (Crataegus). Der Deutsche Apotheker. Heft 11. 1986:387-90.
• 4. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Crataegi folium cum florae. 2nd ed. Thieme. Nortfolk 2003:98-106.
• 5. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Hawthorn.1st ed. American Botanical Council. Newton 2000:182-92.
• 6. Schwinger HG, Pietsch M, Frank K, Brixius K. Crataegus spezial extractWS 1442 increases force of contraction in human myocardium cAMP-independently. J Cardiovasc Pharmacol 2000; 35:700-7.
• 7. W eihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. Fortschr Med 1996; 114:27-9.
• 8. W eiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Stuttgart, New York. Thieme. 2000:149-153.
• 9. Bradley PR. British Herbal compendium. Vol.1. Bournemouth: British Herbal Medicine Association 1992. 10. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Motherwort herb.1st ed. American Botanical Council. Newton 2000:267-9.
• 11. Schmidt U, Albrecht M, Podzuweit H, Ploch M, Maisenbacher J. Hochdosierte Crataegus-Therapie bei herzinsuffizienten Patienten NYHA-Stadium I und II. Z. Phytotherapie 1998; 19:22-30.
• 12. Samochowiec L. Kompendium ziołolecznictwa. Urban & Partner. Wrocław 2002:50-1.
• 13. W eiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Stuttgart, New York. Thieme 2000:206-7.
• 14. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Rosemary leaf.1st ed. American Botanical Council. Newton 2000:326-9.
• 15. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Ginkgo folium. 2nd ed. Thieme. Nortfolk 2003:178-210.
• 16. W eiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Stuttgart, New York. Thieme 2000:159-62.
• 17. D ewick PM. Medicinal natural products. John Wiley & Sons. New York, Toronto 1998:191-2.
• 18. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Ginkgo folium. 2nd ed. Thieme. Nortfolk 2003:188-210.
• 19. R ong Y, Geng Z, Lau BHS. Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Radical Biol Med 1996; 20:121-7.
• 20. Marocci L, Maguire JJ, Droxy-Lefaix MT, Packer L. The nitric oxide scavenging properties of Ginkgo biloba extract ECb 761. Biochem Biophys Commun. 1994; 201:748-55.
• 21. Bastiametto S, Ramassamy C, Dorë S, Christen Y, Poirier J et al. The Ginkgo biloba extract (ECb 761) protects hippocamoalneurones against cell death induced β-amyloid. Eur J Neurosci 2000; 12:1882- 990.
• 22. O ken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998; 55:1409-15.
• 23. E rnst E, Pittler MH. Ginkgo biloba for dementia. A systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17:301-8.
• 24. Stough C, Clarke J, Lloyd J, Nathan PJ. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Internat J Neuropsychopharmacol 2001; 4:131-4.
• 25. K ennedy D, Scholey AB, Wesnes K. Enhacement of cognitive performance by single doses of Ginkgo biloba. J Psychopharmacol 2000;14(Suppl.):A45.
• 26. Harker CT, Marcelon G, Vanhoutte PM. Temperature, oestrogens and contraction of venous smooth muscle of the rabbit. Phleobology 1988; 3(Suppl.):77-82.
• 27. Lauressergues H, Vilain P. Pharmacological activities of Ruscus extract on venous smooth muscle. Int. Angiol. 1984;3:70-73.
• 28. R udolsky C. Venentoniserung und Kapillarbdichtung. Fotschr Med 1989;107:430-4.
• 29. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Rusci rhizoma. 2nd ed. Thieme.Nortfolk 2003:437-44. 30. E MEA . European Medicines Agency. Evaluation of Medicines for Human Use. Ruscus acuelatus L.RHIZOMA. London. 2008.
• 31. Cebo P, Krupinska J, Sobanski H, Mazur J, Czarnecki R. Pharmacological properties of saponin fractionsobteined from domestic crude drugs: Saponaria officinalis, Primula officinalis ans Aesculus hippocastanum. Herba Pol 1976; 22:154-62.
• 32. Maffei F, Carini M, Stefani R, Saibene L. Anti-elastase and anti-hialuronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum and Ruscus aculeatus: factors contributing to their efficacy In the treatment of venous isufficiency. Arch Pharm 1995; 328:720-4.
• 33. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Hippocastani semen. 2nd ed. Thieme. Nortfolk 2003:248-56.
• 34. E MEA . European Medicines Agency. Evaluation of Medicines for Human Use. Aesculus hippocastanum L. SEMEN. London 2008.
• 35. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Horse chestnud seed extract.1st ed. American Botanical Council. Newton 2000:201-4.
• 36. Martin-Aragon S, Basabe B, Benedi JM, Vilar AM. Antioxidant action of Vaccinium myrtillus L. Phytotherapy Res 1998; 12:5104-6.
• 37. Lieti A, Cristoni A, Picci M. Studies on Vaccinium myrtillus anthocyanosides. Vasoprotective and antiinflamatory activity. Arzneim-Forsch/Drug Res 1976; 26:829-32.
• 38. R obert AM, Godeau G, Moati F, Miskulin M. Action of anthocyanosides of Vaccinium myrtillus on he permeability of the blond brain barier. J. Med 1977; 8:321-32.
• 39. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Myrtilli fructus. 2nd ed. Thieme. Nortfolk 2003:345-50.
• 40. Blumenthal M., Goldberg A., Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Linden Flower.1st ed. American Botanical Council. Newton. 2000:16-21.
• 41. W okalek H. Zur Bedeutung epidermaler Lipide und des Arachidonsaurestoffwechsels bei Neurodermitis atopica. Deutsche Dermatologe 1993; 5:498-506.
• 42. E MEA . European Medicines Agency. Evaluation of Medicines for Human Use. Hamamelis virginiana .FOLIUM. London 2008.
• 43. E SCOP Monographs: European Scientific Cooperative on Phytotherapy. Hamaelidis Aqua, H. cortex, H. folium. 2nd ed. Thieme. Nortfolk 2003:223-32.
• 44. Babilliot J. Contribution au traitement de l’insuffisance veineuse par Esberiven. Etude multicentique sur 385 cas. Gaz Med 1980; 87:3242-6.
• 45. K lein L. Tratamiento de las flebopatias con extracto de Melilotus. Pren Med Argent 1967; 54:1191-3. 46. Bisset NG. Meliloti herba. In Herbal drugs and Phytopharmaceuticals. A handbook for practice on a scientific basis. CRC Press. London 1994:326-8.
• 47. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Meliloti herba. 2nd ed. Thieme. Nortfolk 2003:320-23.
• 48. A mmon HPT, Sabieraj J. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und – inhaltsstoffen. Dtsch Apoth Ztg 1996; 136:1821-33.
• 49. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Matricariae flos. 2nd ed. Thieme. Nortfolk 2003:315-19.
• 50. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Yarrow.1st ed. American Botanical Council. Newton 2000:419-22.
• 51. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Popla bud.1st ed. American Botanical Council. Newton 2000:311-13
• 52. Hartisch C, Kołodziej H, von Bruchhausen F. Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipooxygenase and lyso-PAF acetyl-CoA acetyltransferase.Planta Med 1997; 63:106-10.
• 53. E rdelmeier CAJ, Cinatl J, Rabenau H, Doen HW, Biber A. Et al Antiviral and antiphlogistic activities of Hamamelis virginiana. Planta Med 1996; 62:241-5.
• 54. Hughes-Formella BJ, Bohnsack K, Rippke F, Benner G, Rudolph M et al. Anti-inflamatory effect f hamamelis lotion in a UVB erythema test. Dermatology 1998; 196:316-22
• 55. K orting HC, Schäfer-Korting M, Klöwekorn W, Klöwekorn G, Martin C et al. Comparative efficacy ofhamamelis destilate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 1995; 48:461-5.
• 56. Sorkin B. Hametum, eine kortikoidfreie inflamatorische Salbe Phys Med Rehab 1980; 21:53-7.
• 57. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Oak bark.1st ed. American Botanical Council. Newton 2000:278-80.
• 58. W eiss RF, Fintelmann V. 2nd ed. Stuttgart, New York. Thieme. 2000:100-103.
• 59. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Arnicae flos. 2nd ed. Thieme. Nortfolk. 2003:43-7.
• 60. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Allii sativi bulbus. 2nd ed. Thieme. Nortfolk 2003:9814-2 .
• 61. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Linden Flower.1st ed. American Botanical Council. Newton 2000:240-3.
• 62. Foster S, Tyler VE. Tyler’s Honest Herbal. The Haworth Herbal Press. New York, London 1999:247-8.
• 63. Cho JY, Nam KH, Kim AR , Park J, Yoo ES, Baik KU, et al. In vitro and in vivo immunomodulatory effects of syryngin. J. Pharmacol 2001; 53:1287-94.
• 64. W eiss RF, Fintelmann V. 2nd ed. Stuttgart, New York. Thieme 2000:172-3.
• 65. Foster S, Tyler VE. Tyler’s Honest Herbal. The Haworth Herbal Press. New York, London 1999:257-9.
• 66. Schüssler M, Hölzl J, Fricke U. Myocardialeffectsof flavonoids from Crataegus specieds. Arzneim-Forscht Drug Res 1995; 45:842-5.
• 67. Schultz V, Hänsel R, Blumenthal M, Tyler VE. Rational phytotherapy. A reference Guide for Physicians and Pharmacists. 5th Edition. Springer. Berlin, New York 2004:141-44.
• 68. E SCOP Monographs: European Scientific Cooperative On Phytotherapy. Rosmarini folium. 2nd ed. Thieme. Nortfolk 2003:429-36.
• 69. W eiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Stuttgart, New York. Thieme 2000:175-6.